Optimizing pediatric status epilepticus management: The role of early midazolam infusion and adherence to clinical practice guidelines

This study emphasizes that low-dose midazolam infusion, not requiring endotracheal intubation and administered at an early phase, appears to be effective in permanently stopping seizure and preventing the evolution toward a refractory CSE. Given its proven efficacy and widespread use in many hospitals, early midazolam infusion could be considered in the management of pediatric CSE. Adherence to treatment protocols, specific etiologies, and type of CSE are correlated with refractoriness; thus, when facing SE in infants, these factors should guide treatment protocol selection, including medication choice and timing.

Authors

Institutions

Publication Details

Journal
Epilepsia
Published
2025-05-16
DOI
https://doi.org/10.1111/epi.18455
Citations
1
Primary Topic
Epilepsy research and treatment
Type
article
Field-Weighted Citation Impact
1.47

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Optimizing pediatric status epilepticus management: The role of early midazolam infusion and adherence to clinical practice guidelines

Maria Cristina Mondardini, Anna Rosati, Alessandro Simonini, Silvia Pulitanò et al.
1 citations
Epilepsia
Epilepsy research and treatment
1.47
article

Optimizing pediatric status epilepticus management: The role of early midazolam infusion and adherence to clinical practice guidelines

Maria Cristina Mondardini, Anna Rosati, Alessandro Simonini, Silvia Pulitanò, Luca Bergonzini, Patrizia Bartolotta, Fabrizio Chiusolo, Francesca Darra, Domenica Battaglia, Paolo Biban, Federico Vigevano, Duccio Maria Cordelli, Manuela L’Erario, Roberta Vittorini, Alessandra Conio, Emanuele Giacheri, Claudia Bonardi, Elisabetta Cesaroni, Lucia Fusco, Angela Amigoni, Nicola Specchio, Sara Olivotto, Jacopo Proietti, Silvia Buratti, Caterina Zanus, Clarissa Tona, Massimo Mastrangelo, Paola Costa, Stefano Sartori, Carla Marini, Anna Fetta, Francesca Izzo, Giulia Cannizzaro, Emmanuele Mongelli
article en
1 citations

Abstract

This study emphasizes that low-dose midazolam infusion, not requiring endotracheal intubation and administered at an early phase, appears to be effective in permanently stopping seizure and preventing the evolution toward a refractory CSE. Given its proven efficacy and widespread use in many hospitals, early midazolam infusion could be considered in the management of pediatric CSE. Adherence to treatment protocols, specific etiologies, and type of CSE are correlated with refractoriness; thus, when facing SE in infants, these factors should guide treatment protocol selection, including medication choice and timing.

EpilepsiaVol. 66(9)
Università Cattolica del Sacro Cuore (IT), University of Verona (IT), University of Padua (IT), Istituto Giannina Gaslini (IT), Agostino Gemelli University Polyclinic (IT), IRCCS Policlinico San Donato (IT), Provincia Autonoma di Trento (IT), Meyer Children's Hospital (IT), Azienda USL di Bologna (IT), Istituto delle Scienze Neurologiche di Bologna (IT), Bambino Gesù Children's Hospital (IT), Ospedale Regina Margherita (IT), Ospedale dei Bambini Vittore Buzzi (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT), University of Turin (IT), University of Bologna (IT)
Ministero della Salute
Good health and well-being
Openalex Percentile: Top 19%
Epilepsy research and treatment
1.47
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.